Aarti Drugs Q2 FY23 revenue up 19%; Profit down 5.6%
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
The girl child anthem will portray a celebration of a girl child.
Revenue from operations up 26% to Rs. 768 crores
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
Subscribe To Our Newsletter & Stay Updated